Collective Family Office’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.04M | Sell |
5,594
-303
| -5% | -$56.2K | 0.27% | 74 |
|
2025
Q1 | $1.24M | Sell |
5,897
-438
| -7% | -$91.8K | 0.33% | 61 |
|
2024
Q4 | $1.13M | Sell |
6,335
-252
| -4% | -$44.8K | 0.31% | 65 |
|
2024
Q3 | $1.3M | Sell |
6,587
-243
| -4% | -$48K | 0.35% | 61 |
|
2024
Q2 | $1.17M | Sell |
6,830
-120
| -2% | -$20.6K | 0.34% | 67 |
|
2024
Q1 | $1.27M | Sell |
6,950
-174
| -2% | -$31.7K | 0.41% | 55 |
|
2023
Q4 | $1.1M | Sell |
7,124
-85
| -1% | -$13.2K | 0.39% | 59 |
|
2023
Q3 | $1.07M | Sell |
7,209
-705
| -9% | -$105K | 0.42% | 58 |
|
2023
Q2 | $1.07M | Sell |
7,914
-575
| -7% | -$77.5K | 0.42% | 57 |
|
2023
Q1 | $1.35M | Sell |
8,489
-390
| -4% | -$62.2K | 0.56% | 48 |
|
2022
Q4 | $1.43M | Sell |
8,879
-1,804
| -17% | -$292K | 0.64% | 45 |
|
2022
Q3 | $1.43M | Sell |
10,683
-2,954
| -22% | -$397K | 0.71% | 41 |
|
2022
Q2 | $2.09M | Buy |
13,637
+646
| +5% | +$99K | 0.9% | 34 |
|
2022
Q1 | $2.11M | Sell |
12,991
-2,557
| -16% | -$415K | 0.8% | 38 |
|
2021
Q4 | $2.11M | Sell |
15,548
-1,391
| -8% | -$188K | 0.83% | 35 |
|
2021
Q3 | $1.83M | Buy |
16,939
+4
| +0% | +$431 | 0.79% | 34 |
|
2021
Q2 | $1.91M | Sell |
16,935
-899
| -5% | -$101K | 0.82% | 34 |
|
2021
Q1 | $1.93M | Buy |
17,834
+1,777
| +11% | +$192K | 0.94% | 33 |
|
2020
Q4 | $1.72M | Buy |
+16,057
| New | +$1.72M | 0.96% | 29 |
|